Printer Friendly

NEUTROGENA ANNOUNCES IT ANTICIPATES YEAR-END RESULTS TO SHOW GROWTH

 LOS ANGELES, Jan. 18 /PRNewswire/ -- Neutrogena Corp. (NASDAQ: NGNA) today indicated that the company is anticipating its full fiscal year ending Oct. 31, 1993, to show growth over fiscal 1992, although earnings for its first fiscal quarter ending Jan. 31, 1993, will likely be somewhat negatively impacted by events in its European operations.
 Chairman and Chief Executive Officer Lloyd E. Cotsen said, "We have severed relations with our Spanish distributor for performance reasons and are experiencing lower sales, and thus earnings, with one of our major products in Europe due to abnormal weather conditions. Nevertheless, our best estimate now is for a corporate record sales performance in fiscal 1993. We also expect improved earnings for the full year, albeit with quarter to quarter variations as we have experienced before."
 Neutrogena will report the first fiscal quarter in late February, which should show an increase in sales but possibly slightly lower earnings compared with the comparable prior-year period.
 Neutrogena Corp., headquartered in Los Angeles, manufactures and sells high quality, premium-priced specialty skin care and hair care products.
 -0- 1/18/93
 /CONTACT: Donald R. Schort of Neutrogena, 310-642-1150; or Cecilia A. Wilkinson or Roger S. Pondel of Pondel Parsons & Wilkinson, 310-207-9300, for Neutrogena/
 (NGNA)


CO: Neutrogena Corp. ST: California IN: HOU SU: ERP

KJ-JB -- LA016 -- 5974 01/18/93 15:51 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 18, 1993
Words:221
Previous Article:COMPREHENSIVE CARE CORP. REPORTS SECOND QUARTER RESULTS
Next Article:McDONNELL DOUGLAS REALIGNS NON-AEROSPACE BUSINESSES WITH RETIREMENT OF GROUP EXECUTIVE
Topics:


Related Articles
NEUTROGENA VICE PRESIDENT, CHIEF FINANCIAL OFFICER RESIGNS
NEUTROGENA CORP. ANNOUNCES ELIMINATION OF ANIMAL TESTING
NEUTROGENA CORP. ANNOUNCES EARNINGS
NEUTROGENA POSTS HIGHER SALES AND EARNINGS FOR FISCAL YEAR, FOURTH QUARTER
NEUTROGENA REPORTS FIRST QUARTER RESULTS
NEUTROGENA REPORTS SECOND QUARTER RESULTS
NEUTROGENA REPORTS HIGHER SECOND QUARTER SALES AND EARNINGS
NEUTROGENA REPORTS THIRD QUARTER RESULTS
JOHNSON & JOHNSON ACCEPTS MORE THAN 98% OF NEUTROGENA SHARES FOR PAYMENT IN TENDER OFFER

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters